Auris Robotic Endoscopy System for Bronchoscopy

Study summary

In this study, the performance related to the use of the novel Robotic Endoscopy Platform during bronchoscopic procedures will be evaluated.

Ask AI to explain this study

Start here

Key things to know

Main goalDiagnostic

This describes the study’s primary purpose.

What is being studiedRobotic Bronchoscopy Platform

The study team can explain what participation involves.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Nov 15, 2021 · Source: ClinicalTrials.gov

Is enrollment open?Terminated

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?2 U.S. locations

Locations may change over time.

Who runs it?Auris Health, Inc.

Study sponsor

Study overview

What this study is about

Purpose: Diagnostic
Study type: Interventional
Phase: Not applicable
Sponsor: Auris Health, Inc.
Interventions being studied: Device: Robotic Bronchoscopy Platform

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

1. 18 to 80 years of age; 2. Capable and willing to give informed consent; 3. Acceptable candidate for an elective, non-emergent bronchoscopic procedure; 4. Solid peripheral lung lesions suspected of malignancy, between 1.5-7cm in size identified on thin slice CT scan with 30 days of the intended bronchoscopy

Reasons someone may not be able to joinExclusion criteria

1. Medical contraindication to bronchoscopy; 2. Ground glass opacity lesions on pre-procedure CT 3. Participation in any other clinical trial 30 days before and throughout the duration of the study; 4. Uncontrolled or irreversible coagulopathy; 5. Female subjects who are pregnant or nursing or those of child-bearing potential refusing a pregnancy test; 6. CT scan done over a month before the bronchoscopy procedure. Intra-Procedure

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

El Camino HospitalMountain View, California
Palo Alto Medical Foundation Mountain View CenterMountain View, California

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Nov 15, 2021. Always confirm current availability with the study team.

View original record ↗